Recent advances in understanding clonal haematopoiesis in aplastic anaemia

British Journal of Haematology

Volumn 177, Issue 4, 2017, Pages 509-525

  Stanley, Natasha ^a   Olson, Timothy S ^a   Babushok, Daria V ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

aplastic anaemia; bone marrow failure; CHIP; clonal haematopoiesis; MDS

Indexed keywords

HLA ANTIGEN; GENETIC MARKER; SIGNAL PEPTIDE;

AGING; ALLELE; APLASTIC ANEMIA; BONE MARROW DEPRESSION; CYTOGENETICS; GENE DOSAGE; GENETIC VARIATION; HEMATOPOIESIS; HETEROZYGOSITY LOSS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MYELODYSPLASTIC SYNDROME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; X CHROMOSOME; ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; BONE MARROW DISEASE; CELL CLONE; CHILD; DIFFERENTIAL DIAGNOSIS; FEMALE; GENETIC MARKER; GENETICS; IMMUNE EVASION; INFANT; MALE; MIDDLE AGED; MUTATION; MYELODYSPLASTIC SYNDROMES; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PHYSIOLOGY; PRESCHOOL CHILD; RECURRENT DISEASE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, APLASTIC; BONE MARROW DISEASES; CHILD; CHILD, PRESCHOOL; CLONE CELLS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENETIC MARKERS; HEMATOPOIESIS; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; IMMUNE EVASION; INFANT; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MUTATION; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; RECURRENCE; YOUNG ADULT;

EID: 85010002586     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.14510     Document Type: Review

References (117)

1. Abkowitz, J.L., Fialkow, P.J., Niebrugge, D.J., Raskind, W.H. & Adamson, J.W. (1984) Pancytopenia as a clonal disorder of a multipotent hematopoietic stem cell. The Journal of Clinical Investigation, 73, 258–261.
2. Abkowitz, J.L., Catlin, S.N., McCallie, M.T. & Guttorp, P. (2002) Evidence that the number of hematopoietic stem cells per animal is conserved in mammals. Blood, 100, 2665–2667.
3. Afable, M.G. 2nd, Wlodarski, M., Makishima, H., Shaik, M., Sekeres, M.A., Tiu, R.V., Kalaycio, M., O'Keefe, C.L. & Maciejewski, J.P. (2011) SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes. Blood, 117, 6876–6884.
4. Alter, B.P., Giri, N., Savage, S.A., Peters, J.A., Loud, J.T., Leathwood, L., Carr, A.G., Greene, M.H. & Rosenberg, P.S. (2010) Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. British Journal of Haematology, 150, 179–188.
5. Appelbaum, F.R., Barrall, J., Storb, R., Ramberg, R., Doney, K., Sale, G.E. & Thomas, E.D. (1987) Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia. Experimental Hematology, 15, 1134–1139.
6. Babushok, D.V., Xie, H.M., Roth, J.J., Perdigones, N., Olson, T.S., Cockroft, J.D., Gai, X., Perin, J.C., Li, Y., Paessler, M.E., Hakonarson, H., Podsakoff, G.M., Mason, P.J., Biegel, J.A. & Bessler, M. (2014) Single nucleotide polymorphism array analysis of bone marrow failure patients reveals characteristic patterns of genetic changes. British Journal of Haematology, 164, 73–82.
7. Babushok, D.V., Perdigones, N., Perin, J.C., Olson, T.S., Ye, W., Roth, J.J., Lind, C., Cattier, C., Li, Y., Hartung, H., Paessler, M.E., Frank, D.M., Xie, H.M., Cross, S., Cockroft, J.D., Podsakoff, G.M., Monos, D., Biegel, J.A., Mason, P.J. & Bessler, M. (2015a) Emergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemia. Cancer Genetics, 208, 115–128.
8. Babushok, D.V., Olson, T.S. & Bessler, M. (2015b) Somatic mutations and clonal hematopoiesis in aplastic anemia. The New England Journal of Medicine, 373, 1673.
9. Babushok, D.V., Bessler, M. & Olson, T.S. (2016) Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults. Leukemia & Lymphoma, 57, 520–536.
10. Bacigalupo, A., Bruno, B., Saracco, P., Di Bona, E., Locasciulli, A., Locatelli, F., Gabbas, A., Dufour, C., Arcese, W., Testi, G., Broccia, G., Carotenuto, M., Coser, P., Barbui, T., Leoni, P. & Ferster, A. (2000) Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO). Blood, 95, 1931–1934.
11. Betensky, M., Babushok, D., Roth, J.J., Mason, P.J., Biegel, J.A., Busse, T.M., Li, Y., Lind, C., Papazoglou, A., Monos, D., Podsakoff, G., Bessler, M. & Olson, T.S. (2016) Clonal evolution and clinical significance of copy number neutral loss of heterozygosity of chromosome arm 6p in acquired aplastic anemia. Cancer Genetics, 209, 1–10.
12. Busch, K., Klapproth, K., Barile, M., Flossdorf, M., Holland-Letz, T., Schlenner, S.M., Reth, M., Hofer, T. & Rodewald, H.R. (2015) Fundamental properties of unperturbed haematopoiesis from stem cells in vivo. Nature, 518, 542–546.
13. Cao, Q., Gearhart, M.D., Gery, S., Shojaee, S., Yang, H., Sun, H., Lin, D.C., Bai, J.W., Mead, M., Zhao, Z., Chen, Q., Chien, W.W., Alkan, S., Alpermann, T., Haferlach, T., Muschen, M., Bardwell, V.J. & Koeffler, H.P. (2016) BCOR regulates myeloid cell proliferation and differentiation. Leukemia, 30, 1155–1165.
14. Catlin, S.N., Busque, L., Gale, R.E., Guttorp, P. & Abkowitz, J.L. (2011) The replication rate of human hematopoietic stem cells in vivo. Blood, 117, 4460–4466.
15. Challen, G.A., Sun, D., Jeong, M., Luo, M., Jelinek, J., Berg, J.S., Bock, C., Vasanthakumar, A., Gu, H., Xi, Y., Liang, S., Lu, Y., Darlington, G.J., Meissner, A., Issa, J.P., Godley, L.A., Li, W. & Goodell, M.A. (2012) Dnmt3a is essential for hematopoietic stem cell differentiation. Nature Genetics, 44, 23–31.
16. Dameshek, W. (1967) Riddle: what do aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH) and “hypoplastic” leukemia have in common? Blood, 30, 251–254.
17. Desmond, R., Townsley, D.M., Dumitriu, B., Olnes, M.J., Scheinberg, P., Bevans, M., Parikh, A.R., Broder, K., Calvo, K.R., Wu, C.O., Young, N.S. & Dunbar, C.E. (2014) Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug. Blood, 123, 1818–1825.
18. DeZern, A.E., Symons, H.J., Resar, L.S., Borowitz, M.J., Armanios, M.Y. & Brodsky, R.A. (2014) Detection of paroxysmal nocturnal hemoglobinuria clones to exclude inherited bone marrow failure syndromes. European Journal of Haematology, 92, 467–470.
19. Fogarty, P.F., Yamaguchi, H., Wiestner, A., Baerlocher, G.M., Sloand, E., Zeng, W.S., Read, E.J., Lansdorp, P.M. & Young, N.S. (2003) Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Lancet, 362, 1628–1630.
20. Frickhofen, N., Heimpel, H., Kaltwasser, J.P. & Schrezenmeier, H.; German Aplastic Anemia Study, G. (2003) Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood, 101, 1236–1242.
21. Fuhrer, M., Burdach, S., Ebell, W., Gadner, H., Haas, R., Harbott, J., Janka-Schaub, G., Klingebiel, T., Kremens, B., Niemeyer, C., Rampf, U., Reiter, A., Ritter, J., Schulz, A., Walther, U., Zeidler, C. & Bender-Gotze, C. (1998) Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group. Klinische Padiatrie, 210, 173–179.
22. Ganapathi, K.A., Townsley, D.M., Hsu, A.P., Arthur, D.C., Zerbe, C.S., Cuellar-Rodriguez, J., Hickstein, D.D., Rosenzweig, S.D., Braylan, R.C., Young, N.S., Holland, S.M. & Calvo, K.R. (2015) GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia. Blood, 125, 56–70.
23. Gargiulo, L., Papaioannou, M., Sica, M., Talini, G., Chaidos, A., Richichi, B., Nikolaev, A.V., Nativi, C., Layton, M., de la Fuente, J., Roberts, I., Luzzatto, L., Notaro, R. & Karadimitris, A. (2013) Glycosylphosphatidylinositol-specific, CD1d-restricted T cells in paroxysmal nocturnal hemoglobinuria. Blood, 121, 2753–2761.
24. Geary, C.G., Marsh, J.C. & Gordon-Smith, E.C. (1996) Hypoplastic myelodysplasia (MDS). British Journal of Haematology, 94, 582–583.
25. Genovese, G., Kahler, A.K., Handsaker, R.E., Lindberg, J., Rose, S.A., Bakhoum, S.F., Chambert, K., Mick, E., Neale, B.M., Fromer, M., Purcell, S.M., Svantesson, O., Landen, M., Hoglund, M., Lehmann, S., Gabriel, S.B., Moran, J.L., Lander, E.S., Sullivan, P.F., Sklar, P., Gronberg, H., Hultman, C.M. & McCarroll, S.A. (2014) Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. The New England Journal of Medicine, 371, 2477–2487.
26. Gondek, L.P. & DeZern, A.E. (2014) I walk the line: how to tell MDS from other bone marrow failure conditions. Current Hematologic Malignancy Reports, 9, 389–399.
27. Graubert, T.A., Shen, D., Ding, L., Okeyo-Owuor, T., Lunn, C.L., Shao, J., Krysiak, K., Harris, C.C., Koboldt, D.C., Larson, D.E., McLellan, M.D., Dooling, D.J., Abbott, R.M., Fulton, R.S., Schmidt, H., Kalicki-Veizer, J., O'Laughlin, M., Grillot, M., Baty, J., Heath, S., Frater, J.L., Nasim, T., Link, D.C., Tomasson, M.H., Westervelt, P., DiPersio, J.F., Mardis, E.R., Ley, T.J., Wilson, R.K. & Walter, M.J. (2012) Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. Nature Genetics, 44, 53–57.
28. Gupta, V., Brooker, C., Tooze, J.A., Yi, Q.L., Sage, D., Turner, D., Kangasabapathy, P. & Marsh, J.C. (2006) Clinical relevance of cytogenetic abnormalities at diagnosis of acquired aplastic anaemia in adults. British Journal of Haematology, 134, 95–99.
29. Hama, A., Takahashi, Y., Muramatsu, H., Ito, M., Narita, A., Kosaka, Y., Tsuchida, M., Kobayashi, R., Ito, E., Yabe, H., Ohga, S., Ohara, A. & Kojima, S. (2015) Comparison of long-term outcomes between children with aplastic anemia and refractory cytopenia of childhood who received immunosuppressive therapy with antithymocyte globulin and cyclosporine. Haematologica, 100, 1426–1433.
30. Heuser, M., Schlarmann, C., Dobbernack, V., Panagiota, V., Wiehlmann, L., Walter, C., Beier, F., Ziegler, P., Yun, H., Kade, S., Kirchner, A., Huang, L., Koenecke, C., Eder, M., Brummendorf, T.H., Dugas, M., Ganser, A. & Thol, F. (2014) Genetic characterization of acquired aplastic anemia by targeted sequencing. Haematologica, 99, e165–e167.
31. Holbro, A., Jotterand, M., Passweg, J.R., Buser, A., Tichelli, A. & Rovo, A. (2013) Comment to “Favorable outcome of patients who have 13q deletion: a suggestion for revision of the WHO ‘MDS-U’ designation” Haematologica. 2012;97(12):1845-9. Haematologica, 98:e46–e47.
32. Hosokawa, K., Katagiri, T., Sugimori, N., Ishiyama, K., Sasaki, Y., Seiki, Y., Sato-Otsubo, A., Sanada, M., Ogawa, S. & Nakao, S. (2012) Favorable outcome of patients who have 13q deletion: a suggestion for revision of the WHO ‘MDS-U’ designation. Haematologica, 97, 1845–1849.
33. Hosokawa, K., Sugimori, N., Katagiri, T., Sasaki, Y., Saito, C., Seiki, Y., Mochizuki, K., Yamazaki, H., Takami, A. & Nakao, S. (2015) Increased glycosylphosphatidylinositol-anchored protein-deficient granulocytes define a benign subset of bone marrow failures in patients with trisomy 8. European Journal of Haematology, 95, 230–238.
34. Hotta, T., Murate, T., Inoue, C., Kagami, T., Tsushita, K., Wang, J.Y. & Saito, H. (1990) Patchy haemopoiesis in long-term remission of idiopathic aplastic anaemia. European Journal of Haematology, 45, 73–77.
35. Huang, J., Ge, M., Lu, S., Shi, J., Li, X., Zhang, J., Wang, M., Yu, W., Shao, Y., Huang, Z., Zhang, J., Nie, N. & Zheng, Y. (2015) Mutations of ASXL1 and TET2 in aplastic anemia. Haematologica, 100, e172–e175.
36. Huic, D., Ivancevic, V., Aurer, I., Dodig, D., Nemet, D., Labar, B., Poropat, M. & Munz, D.L. (2002) Bone marrow immunoscintigraphy in haematological patients with pancytopenia: preliminary results. Nuclear Medicine Communications, 23, 757–763.
37. Inaguma, Y., Akatsuka, Y., Hosokawa, K., Maruyama, H., Okamoto, A., Katagiri, T., Shiraishi, K., Murayama, Y., Tsuzuki-Iba, S., Mizutani, Y., Nishii, C., Yamamoto, N., Demachi-Okamura, A., Kuzushima, K., Ogawa, S., Emi, N. & Nakao, S. (2016) Induction of HLA-B*40:02-restricted T cells possessing cytotoxic and suppressive functions against haematopoietic progenitor cells from a patient with severe aplastic anaemia. British Journal of Haematology, 172, 131–134.
38. International Agranulocytosis and Aplastic Anemia Study. (1987) Incidence of aplastic anemia: the relevance of diagnostic criteria. Blood, 70, 1718–1721.
39. Ishiyama, K., Karasawa, M., Miyawaki, S., Ueda, Y., Noda, M., Wakita, A., Sawanobori, M., Nagai, H. & Nakao, S. (2002) Aplastic anaemia with 13q-: a benign subset of bone marrow failure responsive to immunosuppressive therapy. British Journal of Haematology, 117, 747–750.
40. Ishiyama, K., Chuhjo, T., Wang, H., Yachie, A., Omine, M. & Nakao, S. (2003) Polyclonal hematopoiesis maintained in patients with bone marrow failure harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells. Blood, 102, 1211–1216.
41. Jacobs, K.B., Yeager, M., Zhou, W., Wacholder, S., Wang, Z., Rodriguez-Santiago, B., Hutchinson, A., Deng, X., Liu, C., Horner, M.J., Cullen, M., Epstein, C.G., Burdett, L., Dean, M.C., Chatterjee, N., Sampson, J., Chung, C.C., Kovaks, J., Gapstur, S.M., Stevens, V.L., Teras, L.T., Gaudet, M.M., Albanes, D., Weinstein, S.J., Virtamo, J., Taylor, P.R., Freedman, N.D., Abnet, C.C., Goldstein, A.M., Hu, N., Yu, K., Yuan, J.M., Liao, L., Ding, T., Qiao, Y.L., Gao, Y.T., Koh, W.P., Xiang, Y.B., Tang, Z.Z., Fan, J.H., Aldrich, M.C., Amos, C., Blot, W.J., Bock, C.H., Gillanders, E.M., Harris, C.C., Haiman, C.A., Henderson, B.E., Kolonel, L.N., Le Marchand, L., McNeill, L.H., Rybicki, B.A., Schwartz, A.G., Signorello, L.B., Spitz, M.R., Wiencke, J.K., Wrensch, M., Wu, X., Zanetti, K.A., Ziegler, R.G., Figueroa, J.D., Garcia-Closas, M., Malats, N., Marenne, G., Prokunina-Olsson, L., Baris, D., Schwenn, M., Johnson, A., Landi, M.T., Goldin, L., Consonni, D., Bertazzi, P.A., Rotunno, M., Rajaraman, P., Andersson, U., Beane Freeman, L.E., Berg, C.D., Buring, J.E., Butler, M.A., Carreon, T., Feychting, M., Ahlbom, A., Gaziano, J.M., Giles, G.G., Hallmans, G., Hankinson, S.E., Hartge, P., Henriksson, R., Inskip, P.D., Johansen, C., Landgren, A., McKean-Cowdin, R., Michaud, D.S., Melin, B.S., Peters, U., Ruder, A.M., Sesso, H.D., Severi, G., Shu, X.O., Visvanathan, K., White, E., Wolk, A., Zeleniuch-Jacquotte, A., Zheng, W., Silverman, D.T., Kogevinas, M., Gonzalez, J.R., Villa, O., Li, D., Duell, E.J., Risch, H.A., Olson, S.H., Kooperberg, C., Wolpin, B.M., Jiao, L., Hassan, M., Wheeler, W., Arslan, A.A., Bueno-de-Mesquita, H.B., Fuchs, C.S., Gallinger, S., Gross, M.D., Holly, E.A., Klein, A.P., LaCroix, A., Mandelson, M.T., Petersen, G., Boutron-Ruault, M.C., Bracci, P.M., Canzian, F., Chang, K., Cotterchio, M., Giovannucci, E.L., Goggins, M., Hoffman Bolton, J.A., Jenab, M., Khaw, K.T., Krogh, V., Kurtz, R.C., McWilliams, R.R., Mendelsohn, J.B., Rabe, K.G., Riboli, E., Tjonneland, A., Tobias, G.S., Trichopoulos, D., Elena, J.W., Yu, H., Amundadottir, L., Stolzenberg-Solomon, R.Z., Kraft, P., Schumacher, F., Stram, D., Savage, S.A., Mirabello, L., Andrulis, I.L., Wunder, J.S., Patino Garcia, A., Sierrasesumaga, L., Barkauskas, D.A., Gorlick, R.G., Purdue, M., Chow, W.H., Moore, L.E., Schwartz, K.L., Davis, F.G., Hsing, A.W., Berndt, S.I., Black, A., Wentzensen, N., Brinton, L.A., Lissowska, J., Peplonska, B., McGlynn, K.A., Cook, M.B., Graubard, B.I., Kratz, C.P., Greene, M.H., Erickson, R.L., Hunter, D.J., Thomas, G., Hoover, R.N., Real, F.X., Fraumeni, J.F. Jr, Caporaso, N.E., Tucker, M., Rothman, N., Perez-Jurado, L.A. & Chanock, S.J. (2012) Detectable clonal mosaicism and its relationship to aging and cancer. Nature Genetics, 44, 651–658.
42. Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P.V., Mar, B.G., Lindsley, R.C., Mermel, C.H., Burtt, N., Chavez, A., Higgins, J.M., Moltchanov, V., Kuo, F.C., Kluk, M.J., Henderson, B., Kinnunen, L., Koistinen, H.A., Ladenvall, C., Getz, G., Correa, A., Banahan, B.F., Gabriel, S., Kathiresan, S., Stringham, H.M., McCarthy, M.I., Boehnke, M., Tuomilehto, J., Haiman, C., Groop, L., Atzmon, G., Wilson, J.G., Neuberg, D., Altshuler, D. & Ebert, B.L. (2014) Age-related clonal hematopoiesis associated with adverse outcomes. The New England Journal of Medicine, 371, 2488–2498.
43. Jameel, T., Anwar, M., Abdi, S.I., Saleem, M., Ahmad, P.A. & Khattak, M.F. (1997) Aplastic anemia or aplastic preleukemic syndrome? Annals of Hematology, 75, 189–193.
44. Jongmans, M.C., Verwiel, E.T., Heijdra, Y., Vulliamy, T., Kamping, E.J., Hehir-Kwa, J.Y., Bongers, E.M., Pfundt, R., van Emst, L., van Leeuwen, F.N., van Gassen, K.L., Geurts van Kessel, A., Dokal, I., Hoogerbrugge, N., Ligtenberg, M.J. & Kuiper, R.P. (2012) Revertant somatic mosaicism by mitotic recombination in dyskeratosis congenita. American Journal of Human Genetics, 90, 426–433.
45. Kaiafa, G., Papadopoulos, A., Ntaios, G., Saouli, Z., Savopoulos, C., Tsesmeli, N., Kontoninas, Z., Chatzinikolaou, A., Tsavdaridou, V., Klonizakis, I. & Hatzitolios, A. (2008) Detection of CD55- and CD59-deficient granulocytic populations in patients with myelodysplastic syndrome. Annals of Hematology, 87, 257–262.
46. Kaito, K., Kobayashi, M., Katayama, T., Masuoka, H., Shimada, T., Nishiwaki, K., Sekita, T., Otsubo, H., Ogasawara, Y. & Hosoya, T. (1998) Long-term administration of G-CSF for aplastic anaemia is closely related to the early evolution of monosomy 7 MDS in adults. British Journal of Haematology, 103, 297–303.
47. Katagiri, T., Sato-Otsubo, A., Kashiwase, K., Morishima, S., Sato, Y., Mori, Y., Kato, M., Sanada, M., Morishima, Y., Hosokawa, K., Sasaki, Y., Ohtake, S., Ogawa, S. & Nakao, S. (2011) Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia. Blood, 118, 6601–6609.
48. Kim, S.Y., Lee, J.W., Lee, S.E., Cho, B.S., Kim, M., Eom, K.S., Kim, Y.J., Kim, H.J., Lee, S., Min, C.K., Cho, S.G., Kim, D.W., Han, K. & Min, W.S. (2010) The characteristics and clinical outcome of adult patients with aplastic anemia and abnormal cytogenetics at diagnosis. Genes Chromosomes Cancer, 49, 844–850.
49. Keel, S.B., Scott, A., Sanchez-Bonilla, M., Ho, P.A., Gulsuner, S., Pritchard, C.C., Abkowitz, J.L., King, M.C., Walsh, T. & Shimamura, A. (2016) Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients. Haematologica, 101, 1343–1350.
50. Kochenderfer, J.N., Kobayashi, S., Wieder, E.D., Su, C. & Molldrem, J.J. (2002) Loss of T-lymphocyte clonal dominance in patients with myelodysplastic syndrome responsive to immunosuppression. Blood, 100, 3639–3645.
51. Kojima, S., Ohara, A., Tsuchida, M., Kudoh, T., Hanada, R., Okimoto, Y., Kaneko, T., Takano, T., Ikuta, K. & Tsukimoto, I.; Japan Childhood Aplastic Anemia Study, G. (2002) Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children. Blood, 100, 786–790.
52. Kulagin, A., Lisukov, I., Ivanova, M., Golubovskaya, I., Kruchkova, I., Bondarenko, S., Vavilov, V., Stancheva, N., Babenko, E., Sipol, A., Pronkina, N., Kozlov, V. & Afanasyev, B. (2014) Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study. British Journal of Haematology, 164, 546–554.
53. Kulasekararaj, A.G., Jiang, J., Smith, A.E., Mohamedali, A.M., Mian, S., Gandhi, S., Gaken, J., Czepulkowski, B., Marsh, J.C. & Mufti, G.J. (2014) Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome. Blood, 124, 2698–2704.
54. Lane, A.A., Odejide, O., Kopp, N., Kim, S., Yoda, A., Erlich, R., Wagle, N., Abel, G.A., Rodig, S.J., Antin, J.H. & Weinstock, D.M. (2013) Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia. Leukemia, 27, 968–971.
55. Laurie, C.C., Laurie, C.A., Rice, K., Doheny, K.F., Zelnick, L.R., McHugh, C.P., Ling, H., Hetrick, K.N., Pugh, E.W., Amos, C., Wei, Q., Wang, L.E., Lee, J.E., Barnes, K.C., Hansel, N.N., Mathias, R., Daley, D., Beaty, T.H., Scott, A.F., Ruczinski, I., Scharpf, R.B., Bierut, L.J., Hartz, S.M., Landi, M.T., Freedman, N.D., Goldin, L.R., Ginsburg, D., Li, J., Desch, K.C., Strom, S.S., Blot, W.J., Signorello, L.B., Ingles, S.A., Chanock, S.J., Berndt, S.I., Le Marchand, L., Henderson, B.E., Monroe, K.R., Heit, J.A., de Andrade, M., Armasu, S.M., Regnier, C., Lowe, W.L., Hayes, M.G., Marazita, M.L., Feingold, E., Murray, J.C., Melbye, M., Feenstra, B., Kang, J.H., Wiggs, J.L., Jarvik, G.P., McDavid, A.N., Seshan, V.E., Mirel, D.B., Crenshaw, A., Sharopova, N., Wise, A., Shen, J., Crosslin, D.R., Levine, D.M., Zheng, X., Udren, J.I., Bennett, S., Nelson, S.C., Gogarten, S.M., Conomos, M.P., Heagerty, P., Manolio, T., Pasquale, L.R., Haiman, C.A., Caporaso, N. & Weir, B.S. (2012) Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nature Genetics, 44, 642–650.
56. Lee, J.H., Kwon, K.A., Lee, S., Oh, S.Y., Kim, S.H., Kwon, H.C., Han, J.Y., Song, M.K., Chung, J.S., Lee, H.S., Kim, Y.S., Lee, S.M., Joo, Y.D. & Kim, H.J. (2010) Incidence and clinical characteristics of clonal cytogenetic abnormalities of acquired aplastic anemia in adults. The Korean Journal of Hematology, 45, 242–246.
57. Li, Y., Li, X., Ge, M., Shi, J., Qian, L., Zheng, Y. & Wang, J. (2011) Long-term follow-up of clonal evolutions in 802 aplastic anemia patients: a single-center experience. Annals of Hematology, 90, 529–537.
58. Link, D.C., Kunter, G., Kasai, Y., Zhao, Y., Miner, T., McLellan, M.D., Ries, R.E., Kapur, D., Nagarajan, R., Dale, D.C., Bolyard, A.A., Boxer, L.A., Welte, K., Zeidler, C., Donadieu, J., Bellanne-Chantelot, C., Vardiman, J.W., Caligiuri, M.A., Bloomfield, C.D., DiPersio, J.F., Tomasson, M.H., Graubert, T.A., Westervelt, P., Watson, M., Shannon, W., Baty, J., Mardis, E.R., Wilson, R.K. & Ley, T.J. (2007) Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia. Blood, 110, 1648–1655.
59. Maciejewski, J.P. & Selleri, C. (2004) Evolution of clonal cytogenetic abnormalities in aplastic anemia. Leukemia & Lymphoma, 45, 433–440.
60. Maciejewski, J.P., Rivera, C., Kook, H., Dunn, D. & Young, N.S. (2001) Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol-anchored protein-deficient clones. British Journal of Haematology, 115, 1015–1022.
61. Maciejewski, J.P., Risitano, A., Sloand, E.M., Nunez, O. & Young, N.S. (2002) Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia. Blood, 99, 3129–3135.
62. Marsh, J.C. & Geary, C.G. (1991) Is aplastic anaemia a pre-leukaemic disorder? British Journal of Haematology, 77, 447–452.
63. Maschek, H., Kaloutsi, V., Rodriguez-Kaiser, M., Werner, M., Choritz, H., Mainzer, K., Dietzfelbinger, M. & Georgii, A. (1993) Hypoplastic myelodysplastic syndrome: incidence, morphology, cytogenetics, and prognosis. Annals of Hematology, 66, 117–122.
64. McKerrell, T., Park, N., Moreno, T., Grove, C.S., Ponstingl, H. & Stephens, J.; Understanding Society Scientific, G., Crawley, C., Craig, J., Scott, M.A., Hodkinson, C., Baxter, J., Rad, R., Forsyth, D.R., Quail, M.A., Zeggini, E., Ouwehand, W., Varela, I. & Vassiliou, G.S. (2015) Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis. Cell Reports, 10, 1239–1245.
65. Mikhailova, N., Sessarego, M., Fugazza, G., Caimo, A., De Filippi, S., van Lint, M.T., Bregante, S., Valeriani, A., Mordini, N., Lamparelli, T., Gualandi, F., Occhini, D. & Bacigalupo, A. (1996) Cytogenetic abnormalities in patients with severe aplastic anemia. Haematologica, 81, 418–422.
66. Minelli, A., Maserati, E., Nicolis, E., Zecca, M., Sainati, L., Longoni, D., Lo Curto, F., Menna, G., Poli, F., De Paoli, E., Cipolli, M., Locatelli, F., Pasquali, F. & Danesino, C. (2009) The isochromosome i(7)(q10) carrying c.258+2t>c mutation of the SBDS gene does not promote development of myeloid malignancies in patients with Shwachman syndrome. Leukemia, 23, 708–711.
67. Mohamedali, A.M., Gaken, J., Ahmed, M., Malik, F., Smith, A.E., Best, S., Mian, S., Gaymes, T., Ireland, R., Kulasekararaj, A.G. & Mufti, G.J. (2015) High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS). Leukemia, 29, 1928–1938.
68. Moran-Crusio, K., Reavie, L., Shih, A., Abdel-Wahab, O., Ndiaye-Lobry, D., Lobry, C., Figueroa, M.E., Vasanthakumar, A., Patel, J., Zhao, X., Perna, F., Pandey, S., Madzo, J., Song, C., Dai, Q., He, C., Ibrahim, S., Beran, M., Zavadil, J., Nimer, S.D., Melnick, A., Godley, L.A., Aifantis, I. & Levine, R.L. (2011) Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell, 20, 11–24.
69. Murakami, Y., Kosaka, H., Maeda, Y., Nishimura, J., Inoue, N., Ohishi, K., Okabe, M., Takeda, J. & Kinoshita, T. (2002) Inefficient response of T lymphocytes to glycosylphosphatidylinositol anchor-negative cells: implications for paroxysmal nocturnal hemoglobinuria. Blood, 100, 4116–4122.
70. Narita, A., Muramatsu, H., Sekiya, Y., Okuno, Y., Sakaguchi, H., Nishio, N., Yoshida, N., Wang, X., Xu, Y., Kawashima, N., Doisaki, S., Hama, A., Takahashi, Y., Kudo, K., Moritake, H., Kobayashi, M., Kobayashi, R., Ito, E., Yabe, H., Ohga, S., Ohara, A. & Kojima, S.; Japan Childhood Aplastic Anemia Study Group. (2015) Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia. Haematologica, 100, 1546–1552.
71. Nazha, A., Seastone, D., Radivoyevitch, T., Przychodzen, B., Carraway, H.E., Patel, B.J., Carew, J., Makishima, H., Sekeres, M.A. & Maciejewski, J.P. (2015) Genomic patterns associated with hypoplastic compared to hyperplastic myelodysplastic syndromes. Haematologica, 100, e434–e437.
72. Ohga, S., Ohara, A., Hibi, S., Kojima, S., Bessho, F., Tsuchiya, S., Ohshima, Y., Yoshida, N., Kashii, Y., Nishimura, S., Kawakami, K., Nishikawa, K. & Tsukimoto, I.; Aplastic Anaemia Committee of the Japanese Society of Paediatric, H. (2002) Treatment responses of childhood aplastic anaemia with chromosomal aberrations at diagnosis. British Journal of Haematology, 118, 313–319.
73. Olnes, M.J., Scheinberg, P., Calvo, K.R., Desmond, R., Tang, Y., Dumitriu, B., Parikh, A.R., Soto, S., Biancotto, A., Feng, X., Lozier, J., Wu, C.O., Young, N.S. & Dunbar, C.E. (2012) Eltrombopag and improved hematopoiesis in refractory aplastic anemia. The New England Journal of Medicine, 367, 11–19.
74. Oo, T.H. (2014) Presence of paroxysmal nocturnal hemoglobinuria clones does not exclude inherited bone marrow failure syndromes. European Journal of Haematology, 93, 171.
75. Parikh, S., Perdigones, N., Paessler, M., Greenbaum, B., Tooke, L.S., Biegel, J.A., Mason, P.J. & Bessler, M. (2012) Acquired copy number neutral loss of heterozygosity of chromosome 7 associated with clonal haematopoiesis in a patient with Shwachman-Diamond syndrome. British Journal of Haematology, 159, 480–482.
76. Perdigones, N., Perin, J.C., Schiano, I., Nicholas, P., Biegel, J.A., Mason, P.J., Babushok, D.V. & Bessler, M. (2016) Clonal hematopoiesis in patients with dyskeratosis congenita. American Journal of Hematology, 91, 1227–1233.
77. Piaggio, G., Podesta, M., Pitto, A., Sessarego, M., Figari, O., Fugazza, G., Benvenuto, F., Bruno, B., Van Lint, M.T., Truini, M., Frassoni, F. & Bacigalupo, A. (1999) Coexistence of normal and clonal haemopoiesis in aplastic anaemia patients treated with immunosuppressive therapy. British Journal of Haematology, 107, 505–511.
78. Pinto, F.O., Leblanc, T., Chamousset, D., Le Roux, G., Brethon, B., Cassinat, B., Larghero, J., de Villartay, J.P., Stoppa-Lyonnet, D., Baruchel, A., Socie, G., Gluckman, E. & Soulier, J. (2009) Diagnosis of Fanconi anemia in patients with bone marrow failure. Haematologica, 94, 487–495.
79. de Planque, M.M., Kluin-Nelemans, H.C., van Krieken, H.J., Kluin, P.M., Brand, A., Beverstock, G.C., Willemze, R. & van Rood, J.J. (1988) Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults. British Journal of Haematology, 70, 55–62.
80. Quentin, S., Cuccuini, W., Ceccaldi, R., Nibourel, O., Pondarre, C., Pages, M.P., Vasquez, N., Dubois d'Enghien, C., Larghero, J., Peffault de Latour, R., Rocha, V., Dalle, J.H., Schneider, P., Michallet, M., Michel, G., Baruchel, A., Sigaux, F., Gluckman, E., Leblanc, T., Stoppa-Lyonnet, D., Preudhomme, C., Socie, G. & Soulier, J. (2011) Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions. Blood, 117, e161–e170.
81. Rosenfeld, S., Follmann, D., Nunez, O. & Young, N.S. (2003) Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA: The Journal of the American Medical Association, 289, 1130–1135.
82. Scheinberg, P., Townsley, D., Dumitriu, B., Scheinberg, P., Weinstein, B., Daphtary, M., Rios, O., Wu, C.O. & Young, N.S. (2014a) Moderate-dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution. Blood, 124, 2820–2823.
83. Scheinberg, P., Rios, O., Scheinberg, P., Weinstein, B., Wu, C.O. & Young, N.S. (2014b) Prolonged cyclosporine administration after antithymocyte globulin delays but does not prevent relapse in severe aplastic anemia. American Journal of Hematology, 89, 571–574.
84. Score, J., Chase, A., Forsberg, L.A., Feng, L., Waghorn, K., Jones, A.V., Rasi, C., Linch, D.C., Dumanski, J.P., Gale, R.E. & Cross, N.C. (2015) Detection of leukemia-associated mutations in peripheral blood DNA of hematologically normal elderly individuals. Leukemia, 29, 1600–1602.
85. Sloand, E.M., Kim, S., Fuhrer, M., Risitano, A.M., Nakamura, R., Maciejewski, J.P., Barrett, A.J. & Young, N.S. (2002) Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities. Blood, 100, 4427–4432.
86. Sloand, E.M., Mainwaring, L., Fuhrer, M., Ramkissoon, S., Risitano, A.M., Keyvanafar, K., Lu, J., Basu, A., Barrett, A.J. & Young, N.S. (2005) Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome. Blood, 106, 841–851.
87. Sloand, E.M., Yong, A.S., Ramkissoon, S., Solomou, E., Bruno, T.C., Kim, S., Fuhrer, M., Kajigaya, S., Barrett, A.J. & Young, N.S. (2006) Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor. Proceedings of the National Academy of Sciences of the United States of America, 103, 14483–14488.
88. Sloand, E.M., Wu, C.O., Greenberg, P., Young, N. & Barrett, J. (2008) Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy. Journal of Clinical Oncology, 26, 2505–2511.
89. Smith, J.N., Kanwar, V.S. & MacNamara, K.C. (2016) Hematopoietic stem cell regulation by type I and II interferons in the pathogenesis of acquired aplastic anemia. Frontiers in Immunology, 7, 330.
90. Socie, G. (1996) Could aplastic anaemia be considered a pre-pre-leukaemic disorder?. European Journal of Haematology Supplementum, 60, 60–63.
91. Socie, G., Henry-Amar, M., Bacigalupo, A., Hows, J., Tichelli, A., Ljungman, P., McCann, S.R., Frickhofen, N., Van't Veer-Korthof, E. & Gluckman, E. (1993) Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. The New England Journal of Medicine, 329, 1152–1157.
92. Soulier, J., Leblanc, T., Larghero, J., Dastot, H., Shimamura, A., Guardiola, P., Esperou, H., Ferry, C., Jubert, C., Feugeas, J.P., Henri, A., Toubert, A., Socie, G., Baruchel, A., Sigaux, F., D'Andrea, A.D. & Gluckman, E. (2005) Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway. Blood, 105, 1329–1336.
93. Steele, J.M., Sung, L., Klaassen, R., Fernandez, C.V., Yanofsky, R., Wu, J., Odame, I., Silva, M., Champagne, J., Ali, K., Brossard, J., Samson, Y., Abish, S., Le, D., Jardine, L., Hand, J.P., Lipton, J.H., Charpentier, K., Stephens, D., Freedman, M. & Dror, Y.; Canadian Inherited Marrow Failure, R. (2006) Disease progression in recently diagnosed patients with inherited marrow failure syndromes: a Canadian Inherited Marrow Failure Registry (CIMFR) report. Pediatric Blood & Cancer, 47, 918–925.
94. Sugimori, C., Chuhjo, T., Feng, X., Yamazaki, H., Takami, A., Teramura, M., Mizoguchi, H., Omine, M. & Nakao, S. (2006) Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia. Blood, 107, 1308–1314.
95. Sutherland, D.R., Keeney, M. & Illingworth, A. (2012) Practical guidelines for the high-sensitivity detection and monitoring of paroxysmal nocturnal hemoglobinuria clones by flow cytometry. Cytometry Part B Clinical Cytometry, 82, 195–208.
96. Teramura, M., Kimura, A., Iwase, S., Yonemura, Y., Nakao, S., Urabe, A., Omine, M. & Mizoguchi, H. (2007) Treatment of severe aplastic anemia with antithymocyte globulin and cyclosporin A with or without G-CSF in adults: a multicenter randomized study in Japan. Blood, 110, 1756–1761.
97. Tichelli, A., Gratwohl, A., Wursch, A., Nissen, C. & Speck, B. (1988) Late haematological complications in severe aplastic anaemia. British Journal of Haematology, 69, 413–418.
98. Tichelli, A., Schrezenmeier, H., Socie, G., Marsh, J., Bacigalupo, A., Duhrsen, U., Franzke, A., Hallek, M., Thiel, E., Wilhelm, M., Hochsmann, B., Barrois, A., Champion, K. & Passweg, J.R. (2011) A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation. Blood, 117, 4434–4441.
99. Tisdale, J.F., Maciejewski, J.P., Nunez, O., Rosenfeld, S.J. & Young, N.S. (2002) Late complications following treatment for severe aplastic anemia (SAA) with high-dose cyclophosphamide (Cy): follow-up of a randomized trial. Blood, 100, 4668–4670.
100. Tripathi, P., Tripathi, A.K., Kumar, A., Ahmad, R., Balapure, A.K., Vishwakerma, A.L. & Singh, R.K. (2008) DNA aneuploidy study for early detection of chromosomal abnormality in patients with aplastic anemia: prognostic and therapeutic implications. In Vivo, 22, 837–844.
101. Tutelman, P.R., Aubert, G., Milner, R.A., Dalal, B.I., Schultz, K.R. & Deyell, R.J. (2014) Paroxysmal nocturnal haemoglobinuria phenotype cells and leucocyte subset telomere length in childhood acquired aplastic anaemia. British Journal of Haematology, 164, 717–721.
102. Tuzuner, N., Cox, C., Rowe, J.M., Watrous, D. & Bennett, J.M. (1995) Hypocellular myelodysplastic syndromes (MDS): new proposals. British Journal of Haematology, 91, 612–617.
103. Vardiman, J.W., Thiele, J., Arber, D.A., Brunning, R.D., Borowitz, M.J., Porwit, A., Harris, N.L., Le Beau, M.M., Hellstrom-Lindberg, E., Tefferi, A. & Bloomfield, C.D. (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood, 114, 937–951.
104. Venkatraj, V.S., Gaidano, G. & Auerbach, A.D. (1994) Clonality studies and N-ras and p53 mutation analysis of hematopoietic cells in Fanconi anemia. Leukemia, 8, 1354–1358.
105. Walter, M.J., Shen, D., Shao, J., Ding, L., White, B.S., Kandoth, C., Miller, C.A., Niu, B., McLellan, M.D., Dees, N.D., Fulton, R., Elliot, K., Heath, S., Grillot, M., Westervelt, P., Link, D.C., DiPersio, J.F., Mardis, E., Ley, T.J., Wilson, R.K. & Graubert, T.A. (2013) Clonal diversity of recurrently mutated genes in myelodysplastic syndromes. Leukemia, 27, 1275–1282.
106. Wang, H., Chuhjo, T., Yasue, S., Omine, M. & Nakao, S. (2002) Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria-type cells in bone marrow failure syndrome. Blood, 100, 3897–3902.
107. Wang, S.A., Pozdnyakova, O., Jorgensen, J.L., Medeiros, L.J., Stachurski, D., Anderson, M., Raza, A. & Woda, B.A. (2009) Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats. Haematologica, 94, 29–37.
108. West, R.R., Hsu, A.P., Holland, S.M., Cuellar-Rodriguez, J. & Hickstein, D.D. (2014) Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation. Haematologica, 99, 276–281.
109. Wlodarski, M.W., Hirabayashi, S., Pastor, V., Stary, J., Hasle, H., Masetti, R., Dworzak, M., Schmugge, M., van den Heuvel-Eibrink, M., Ussowicz, M., De Moerloose, B., Catala, A., Smith, O.P., Sedlacek, P., Lankester, A.C., Zecca, M., Bordon, V., Matthes-Martin, S., Abrahamsson, J., Kuhl, J.S., Sykora, K.W., Albert, M.H., Przychodzien, B., Maciejewski, J.P., Schwarz, S., Gohring, G., Schlegelberger, B., Cseh, A., Noellke, P., Yoshimi, A., Locatelli, F., Baumann, I., Strahm, B. & Niemeyer, C.M. (2016) Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents. Blood, 127, 1387–1397; quiz 1518.
110. Wu, X., Bekker-Jensen, I.H., Christensen, J., Rasmussen, K.D., Sidoli, S., Qi, Y., Kong, Y., Wang, X., Cui, Y., Xiao, Z., Xu, G., Williams, K., Rappsilber, J., Sonderby, C.K., Winther, O., Jensen, O.N. & Helin, K. (2015) Tumor suppressor ASXL1 is essential for the activation of INK4B expression in response to oncogene activity and anti-proliferative signals. Cell Research, 25, 1205–1218.
111. Xie, M., Lu, C., Wang, J., McLellan, M.D., Johnson, K.J., Wendl, M.C., McMichael, J.F., Schmidt, H.K., Yellapantula, V., Miller, C.A., Ozenberger, B.A., Welch, J.S., Link, D.C., Walter, M.J., Mardis, E.R., Dipersio, J.F., Chen, F., Wilson, R.K., Ley, T.J. & Ding, L. (2014) Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nature Medicine, 20, 1472–1478.
112. Yamaguchi, H., Baerlocher, G.M., Lansdorp, P.M., Chanock, S.J., Nunez, O., Sloand, E. & Young, N.S. (2003) Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. Blood, 102, 916–918.
113. Yamaguchi, H., Calado, R.T., Ly, H., Kajigaya, S., Baerlocher, G.M., Chanock, S.J., Lansdorp, P.M. & Young, N.S. (2005) Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. The New England Journal of Medicine, 352, 1413–1424.
114. Yoshizato, T., Dumitriu, B., Hosokawa, K., Makishima, H., Yoshida, K., Townsley, D., Sato-Otsubo, A., Sato, Y., Liu, D., Suzuki, H., Wu, C.O., Shiraishi, Y., Clemente, M.J., Kataoka, K., Shiozawa, Y., Okuno, Y., Chiba, K., Tanaka, H., Nagata, Y., Katagiri, T., Kon, A., Sanada, M., Scheinberg, P., Miyano, S., Maciejewski, J.P., Nakao, S., Young, N.S. & Ogawa, S. (2015) Somatic mutations and clonal hematopoiesis in aplastic anemia. The New England Journal of Medicine, 373, 35–47.
115. Young, N.S. & Ogawa, S. (2015) Somatic mutations and clonal hematopoiesis in aplastic anemia. The New England Journal of Medicine, 373, 1675–1676.
116. Young, A.L., Challen, G.A., Birmann, B.M. & Druley, T.E. (2016) Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults. Nature Communications, 7, 12484.
117. Zhao, X., Zhang, L., Jing, L., Zhou, K., Li, Y., Peng, G., Ye, L., Li, Y., Li, J., Fan, H., Song, L., Yang, W. & Zhang, F. (2015) The role of paroxysmal nocturnal hemoglobinuria clones in response to immunosuppressive therapy of patients with severe aplastic anemia. Annals of Hematology, 94, 1105–1110.